companiesCompany
MediLink Therapeutics
MediLink developed the TMALIN ADC linker platform, licensed to Zai Lab, BioNTech, and Roche.
YL201 (B7-H3, phase 3 SCLC), ZL-6201 (LRRC15 with Zai Lab), Roche c-MET ADC deal.
MediLink developed the TMALIN ADC linker platform, licensed to Zai Lab, BioNTech, and Roche.
YL201 (B7-H3, phase 3 SCLC), ZL-6201 (LRRC15 with Zai Lab), Roche c-MET ADC deal.